The role of microbiota in pathogenesis and development of viral infections
DOI:
https://doi.org/10.12775/JEHS.2021.11.12.025Keywords
microbiota, dysbiosis, virus infection, HIV, SARS-CoV-2Abstract
Introduction and purpose
The microbiota plays an important role in human metabolism, immune system, and development of many chronic diseases, cancers, and infectious diseases. The aim of the study is to present the role of gut microbiota in viral infections, including HBV, Herpesviridae, HIV, and SARS-CoV-2. The newest publications from the last 5 years available on the PubMed database were taken into account.
A brief description of the state of knowledge
The mechanism by which bacterias have an impact on viral infection is based on a synthesis of specific short-chain fatty acids (SCFAs) and modulation of cytokine release and immune system function by bacterias. Domination of Gardnerella vaginalis and lack of Lactobacillus in the vaginal microbiome increased the risk of HSV-2 infection in women. Inflammation of the genital tract can influence susceptibility to HIV infection, but probiotics via enhancement of the gut barrier integrity, change TH17/Treg ratio, can restore microbiome composition. LPS - component of the structure of Gram-negative bacteria can be a marker of HBV infection. In the airway microbiome of patients with COVID-19 opportunistic microorganisms were identified.
Conclusions
Diet, intake of probiotics, fecal microbiota transplantation (FMT) are interventions that might be efficient methods in prophylaxis and treatment of viral diseases. Further studies are needed to evaluate the mechanism of action of microbiome in pathogenesis of infectious diseases.
References
Vujkovic-Cvijin I, Somsouk M. HIV and the gut microbiota: composition, consequences, and avenues for amelioration. Curr HIV/AIDS Rep. 2019 Jun;16(3):204-213. doi: 10.1007/s11904-019-00441-w. PMID: 31037552; PMCID: PMC6579656.
Yang R, Xu Y, Dai Z, Lin X, Wang H. The immunologic role of gut microbiota in patients with chronic HBV infection. J Immunol Res. 2018 Jul 25;2018:2361963. doi: 10.1155/2018/2361963. PMID: 30148173; PMCID: PMC6083645.
D'Angelo C, Reale M, Costantini E. Microbiota and probiotics in health and HIV infection. Nutrients. 2017 Jun 16;9(6):615. doi: 10.3390/nu9060615. PMID: 28621726; PMCID: PMC5490594.
Lee A, Hong J, Shin DY, Koh Y, Yoon SS, Kim PJ, Kim HG, Kim I, Park HK, Choi Y. Association of HSV-1 and reduced oral bacteriota diversity with chemotherapy-induced oral mucositis in patients undergoing autologous hematopoietic stem cell transplantation. J Clin Med. 2020 Apr 11;9(4):1090. doi: 10.3390/jcm9041090. PMID: 32290456; PMCID: PMC7230275.
Liu TFD, Philippou E, Kolokotroni O, Siakallis G, Rahima K, Constantinou C. Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review. Infection. 2021 Oct 20:1–33. doi: 10.1007/s15010-021-01715-5. Epub ahead of print. PMID: 34671922; PMCID: PMC8528184.
Hills RD Jr, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR. Gut microbiome: profound implications for diet and disease. Nutrients. 2019 Jul 16;11(7):1613. doi: 10.3390/nu11071613. PMID: 31315227; PMCID: PMC6682904.
Kuijper EJ, Vehreschild MJGT. Clinical microbiota and infection. Clin Microbiol Infect. 2020 Nov;26(11):1447. doi: 10.1016/j.cmi.2020.09.029. Epub 2020 Sep 18. PMID: 32956870.
Bottari B, Castellone V, Neviani E. Probiotics and Covid-19. Int J Food Sci Nutr. 2021 May;72(3):293-299. doi: 10.1080/09637486.2020.1807475. Epub 2020 Aug 12. PMID: 32787470.
Shannon B, Gajer P, Yi TJ, Ma B, Humphrys MS, Thomas-Pavanel J, Chieza L, Janakiram P, Saunders M, Tharao W, Huibner S, Shahabi K, Ravel J, Kaul R. Distinct effects of the cervicovaginal microbiota and herpes simplex type 2 infection on female genital tract immunology. J Infect Dis. 2017 May 1;215(9):1366-1375. doi: 10.1093/infdis/jix088. PMID: 28201724; PMCID: PMC5451606.
Torcia MB. Interplay among vaginal microbiome, immune response and sexually transmitted viral infections. Int J Mol Sci 2019; 20:266.
Mehta SD, Nandi D, Agingu W, Green SJ, Bhaumik DK, Bailey RC, Otieno F. Vaginal and penile microbiome associations with HSV-2 in women and their male sex partners. J Infect Dis. 2020 Aug 21:jiaa529. doi: 10.1093/infdis/jiaa529. Epub ahead of print. PMID: 32822500.
Yuan L, Hensley C, Mahsoub HM, Ramesh AK, Zhou P. Microbiota in viral infection and disease in humans and farm animals. Prog Mol Biol Transl Sci. 2020;171:15-60. doi: 10.1016/bs.pmbts.2020.04.005. Epub 2020 Apr 24. PMID: 32475521; PMCID: PMC7181997.
Kang Y, Cai Y. Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy. J Hosp Infect. 2017 Aug;96(4):342-348. doi: 10.1016/j.jhin.2017.04.007. Epub 2017 Apr 15. PMID: 28545829.
Borrelli A., Bonelli P., Tuccillo F. M., et al. Role of gut microbiota and oxidative stress in the progression of non-alcoholic fatty liver disease to hepatocarcinoma: current and innovative therapeutic approaches. Redox Biology. 2018;15:467–479. doi: 10.1016/j.redox.2018.01.009.
Silva FAFD, Brito BB, Santos MLC, Marques HS, Silva Júnior RTD, Carvalho LS, Vieira ES, Oliveira MV, Melo FF. COVID-19 gastrointestinal manifestations: a systematic review. Rev Soc Bras Med Trop. 2020 Nov 25;53:e20200714. doi: 10.1590/0037-8682-0714-2020. PMID: 33263693; PMCID: PMC7723378.
Dhar D, Mohanty A. Gut microbiota and Covid-19- possible link and implications. Virus Res. 2020 Aug;285:198018. doi: 10.1016/j.virusres.2020.198018. Epub 2020 May 13. PMID: 32430279; PMCID: PMC7217790.
Yeoh YK, Zuo T, Lui GC-Y, Zhang F, Liu Q, Li AY, et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698–706. doi: 10.1136/gutjnl-2020-323020.
Tang L, Gu S, Gong Y, Li B, Lu H, Li Q, et al. Clinical significance of the correlation between changes in the major intestinal bacteria species and COVID-19 severity. Engineering. 2020;6:1178–1184. doi: 10.1016/j.eng.2020.05.013.
Liu F, Ye S, Zhu X, He X, Wang S, Li Y, et al. Gastrointestinal disturbance and effect of fecal microbiota transplantation in discharged COVID-19 patients. J Med Case Rep. 2021;15:60. doi: 10.1186/s13256-020-02583-7.
Rueca M, Fontana A, Bartolini B, Piselli P, Mazzarelli A, Copetti M, et al. Investigation of nasal/oropharyngeal microbial community of COVID-19 patients by 16S rDNA sequencing. Int J Environ Res Public Health. 2021;18:2174. doi: 10.3390/ijerph18042174.
Nardelli C, Gentile I, Setaro M, Di Domenico C, Pinchera B, Buonomo AR, Zappulo E, Scotto R, Scaglione GL, Castaldo G, Capoluongo E. Nasopharyngeal microbiome signature in COVID-19 positive patients: can we definitively get a role to Fusobacterium periodonticum? Front Cell Infect Microbiol. 2021 Feb 15;11:625581. doi: 10.3389/fcimb.2021.625581. PMID: 33659220; PMCID: PMC7919745.
Merenstein C, Liang G, Whiteside SA, Cobián-Güemes AG, Merlino MS, Taylor LJ, et al. Signatures of COVID-19 severity and immune response in the respiratory tract microbiome. Infect Dis (Except HIV/AIDS) 2021 doi: 10.1101/2021.04.02.21254514.
Shi HY, Zhu X, Li WL, Mak JWY, Wong SH, Zhu ST, et al. Modulation of gut microbiota protects against viral respiratory tract infections: a systematic review of animal and clinical studies. Eur J Nutr. 2021 doi: 10.1007/s00394-021-02519-x.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Marcela Maksymowicz, Gabriela Ręka, Piotr Machowiec, Halina Piecewicz-Szczęsna
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 398
Number of citations: 0
